Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
Needham analyst Michael Matson maintained a Hold rating on Inogen (INGN – Research Report) today. The company’s shares closed yesterday at $9.46. Matson covers the Healthcare sector, focusing on ...
Needham analyst Michael Matson maintained a Hold rating on Inogen (INGN – Research Report) today. The company’s shares closed yesterday at $9.34. Matson covers the Healthcare sector, focusing on ...